Ultralow prostate-specific antigen nadir after apalutamide: outcomes in synchronous vrsus metachronous metastatic hormone-sensitive prostate cancer - Wenzel, Mike; Steuber, Thomas; Siech, Carolin; Kriegmair, Maximilian; Hoeh, Benedikt; Tilki, Derya; Merseburger, Axel S.; Chun, Felix K. H.; Mandel, Philipp (European urology open science, 2025)
Online verfügbar: 3. Juni 2025, Artikelversion: 3. Juni 2025